0001209191-21-007724.txt : 20210204
0001209191-21-007724.hdr.sgml : 20210204
20210204161915
ACCESSION NUMBER: 0001209191-21-007724
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210204
DATE AS OF CHANGE: 20210204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ahmadzai David
CENTRAL INDEX KEY: 0001813060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12537
FILM NUMBER: 21591407
MAIL ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXTGEN HEALTHCARE, INC.
CENTRAL INDEX KEY: 0000708818
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
IRS NUMBER: 952888568
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
BUSINESS PHONE: 404-467-1500
MAIL ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
FORMER COMPANY:
FORMER CONFORMED NAME: QUALITY SYSTEMS, INC
DATE OF NAME CHANGE: 20180823
FORMER COMPANY:
FORMER CONFORMED NAME: NEXTGEN HEALTHCARE, INC
DATE OF NAME CHANGE: 20180823
FORMER COMPANY:
FORMER CONFORMED NAME: QUALITY SYSTEMS, INC
DATE OF NAME CHANGE: 20100804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-03
0
0000708818
NEXTGEN HEALTHCARE, INC.
NXGN
0001813060
Ahmadzai David
3525 PIEDMONT RD., NE
BUILDING 6, SUITE 700
ATLANTA
GA
30305
0
1
0
0
Chief Accounting Officer
Common Stock
2021-02-03
4
M
0
3250
16.37
A
36952
D
Common Stock
2021-02-03
4
M
0
1500
16.64
A
38452
D
Common Stock
2021-02-03
4
M
0
3000
16.83
A
41452
D
Common Stock
2021-02-03
4
S
0
10446
19.6122
D
31006
D
Non-Qualified Stock option (right to buy)
16.37
2021-02-03
4
M
0
3250
0.00
D
2025-06-13
Common Stock
3250
3250
D
Non-Qualified Stock option (right to buy)
16.64
2021-02-03
4
M
0
1500
0.00
D
2023-05-22
Common Stock
1500
0
D
Non-Qualified Stock option (right to buy)
16.83
2021-02-03
4
M
0
3000
0.00
D
2026-06-01
Common Stock
3000
6000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.5801 to $19.67, inclusive. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
Options exercised vested on June 13, 2020. Remaining options reported in column 9 will vest on June 13, 2021.
Options exercised vested on May 22, 2020.
Options exercised vested on June 1, 2020. Remaining options reported in column 9 will vest on June 1, 2021 and June 1, 2022.
Jeffrey D. Linton, Attorney-in-Fact for David Ahmadzai
2021-02-04